Updated: Editas abruptly terminates CMO Lisa Michaels, revealing little in terse SEC filing
In a surprise move, Editas Medicine parted with its top physician late Monday afternoon, noting in an SEC filing that CMO Lisa Michaels was “terminated, effective immediately.”
The biotech did not give a reason for the decision. Monday’s SEC filing only outlined her severance package, and Editas did not put out a corresponding press release. Company spokesperson Cristi Barnett wrote to Endpoints News in an email that the company will begin an external search, but provided no timeline.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 151,400+ biopharma pros reading Endpoints daily — and it's free.